These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10356816)

  • 1. Gel approved for KS.
    AIDS Patient Care STDS; 1999 May; 13(5):309. PubMed ID: 10356816
    [No Abstract]   [Full Text] [Related]  

  • 2. KS drug goes to FDA. Food and Drug Administration.
    GMHC Treat Issues; 1998 May; 12(5):7. PubMed ID: 11365479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
    Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
    Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral treatment for KS.
    Posit Aware; 1998; 9(5):18. PubMed ID: 11365887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early approval for two lipid-based drugs.
    Baker R
    BETA; 1995 Dec; ():4. PubMed ID: 11363009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma: new topical treatment approved.
    James JS
    AIDS Treat News; 1999 Feb; (No 313):1. PubMed ID: 11366235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
    Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 0.1% alitretinoin gel for classic Kaposi sarcoma.
    Morganroth GS
    Arch Dermatol; 2002 Apr; 138(4):542-3. PubMed ID: 11939830
    [No Abstract]   [Full Text] [Related]  

  • 9. Alitretinoin (Panretin) gel 0.1%.
    Rhoads J
    J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kaposi's sarcoma treated with topical alitretinoin].
    González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
    Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-related Kaposi sarcoma: the role of local therapy for a systemic disease.
    Dezube BJ
    Arch Dermatol; 2000 Dec; 136(12):1554-6. PubMed ID: 11115173
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA news. Food and Drug Administration.
    Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 16. Clearance given for Panretin gel.
    Oncologist; 1999; 4(2):187. PubMed ID: 10337390
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-cancer agents.
    TreatmentUpdate; 1998 Jun; 10(4):1-6. PubMed ID: 11365440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV plus hepatitis C or Kaposi sarcoma. Treatment options in coinfection].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():58-9. PubMed ID: 10863315
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose paclitaxel effective in advanced KS.
    Bartnof HS
    BETA; 1997 Sep; ():51. PubMed ID: 11364705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.